Alberto Pappo
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alberto Pappo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:59 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06023641 · Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk DiseaseSt. Jude Children's Research Hospital · recruiting · Rhabdomyosarcoma · principal investigator
- N/ANCT03276702 · Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid MalignanciesSt. Jude Children's Research Hospital · completed · Tumor, Solid · principal investigator
- N/ANCT02775643 · Molecular Analysis of Childhood and Adolescent Melanocytic LesionsSt. Jude Children's Research Hospital · recruiting · Melanoma · principal investigator
- Ph2NCT00539591 · Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk MelanomaSt. Jude Children's Research Hospital · active not recruiting · Malignant Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in rhabdomyosarcoma, ranked by citations from NIH iCite, fetched 2026-11-12 11:59 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.J Clin Oncol · 2006284 citationsRCR 6.8
- Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children.J Clin Oncol · 1999190 citationsRCR 4.4
- 167 citationsRCR 5.0
- 153 citationsRCR 3.9
- 122 citationsRCR 3.8
- Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study.J Clin Oncol · 200192 citationsRCR 2.3
- 79 citationsRCR 2.1
- Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group.Pediatr Blood Cancer · 201159 citationsRCR 1.6
- A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.Cancer · 199337 citationsRCR 1.5
- Feasibility of indocyanine green-guided localization of pulmonary nodules in children with solid tumors.Pediatr Blood Cancer · 202329 citationsRCR 5.6